These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

615 related items for PubMed ID: 7332791

  • 1. [Breast cancer and use of antihypertensive drugs and oral contraceptives: results of a case-control study (author's transl)].
    Clavel F, Lê M, Laplanche A.
    Bull Cancer; 1981; 68(5):449-55. PubMed ID: 7332791
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Incidence of arterial hypertension in women taking oral hormonal contraceptive agents (femigen)].
    Mikrut W.
    Wiad Lek; 1983 Oct 01; 36(19):1587-92. PubMed ID: 6198806
    [Abstract] [Full Text] [Related]

  • 6. [Amenorrhea after hormonal contraception. Prophylaxis, findings and therapy].
    Kunz J.
    Gynakol Rundsch; 1976 Oct 01; 16(1):47-64. PubMed ID: 986984
    [No Abstract] [Full Text] [Related]

  • 7. [Effects of hormonal contraceptives on the female breast (author's transl)].
    Tapia JE, Mall-Haefeli M.
    Schweiz Rundsch Med Prax; 1977 Feb 22; 66(8):223-6. PubMed ID: 557204
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women.
    Gammon MD, Hibshoosh H, Terry MB, Bose S, Schoenberg JB, Brinton LA, Bernstein JL, Thompson WD.
    Cancer Epidemiol Biomarkers Prev; 1999 May 22; 8(5):413-9. PubMed ID: 10350436
    [Abstract] [Full Text] [Related]

  • 12. [Behaviour of ujoviridin exposure test (ICG) in conjunction with application of hormonal contraceptives (author's transl)].
    Brügmann E, Göretzlehner G.
    Zentralbl Gynakol; 1981 May 22; 103(14):823-6. PubMed ID: 7293553
    [Abstract] [Full Text] [Related]

  • 13. Case-control study of antihypertensive and diuretic use by women with malignant and benign breast lesions detected in a mammography screening program.
    Williams RR, Feinleib M, Connor RJ, Stegens NL.
    J Natl Cancer Inst; 1978 Aug 22; 61(2):327-35. PubMed ID: 277719
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Oral contraceptives and breast cancer].
    Zoricić D, Ambrozić B, Perić D.
    Lijec Vjesn; 1998 Dec 22; 120(12):392-7. PubMed ID: 19658362
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Breast cancer and oral contraceptives: critique of the proposition that high potency progestogen products confer excess risk.
    Sturtevant FM.
    Biomed Pharmacother; 1984 Dec 22; 38(8):371-9. PubMed ID: 6525434
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.